ConductScience.org, home

Paper39769334

Targeting Cancer: Microenvironment and Immunotherapy Innovations.

Padzińska-Pruszyńska IB and 9 others. Int J Mol Sci, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Targeting Cancer: Microenvironment and Immunotherapy Innovations. Papers, record 39769334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39769334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting Cancer: Microenvironment and Immunotherapy Innovations.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.51, provisional
iCite
Revised in PubMed
2026-09-24
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Padzińska-Pruszyńska IBIrena Barbara
2Taciak BBartłomiej
3Kiraga ŁŁukasz
4Smolarska AAnnahttps://orcid.org/0000-0001-6995-6316
5Górczak MMałgorzatahttps://orcid.org/0000-0001-5383-6096
6Kucharzewska PPaulina
7Kubiak MMałgorzata
8Szeliga JJacek
9Matejuk AAgata
10Król MMagdalena

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
NeoplasmsMajor topic
ImmunotherapyMajor topic
Humans
Lymphocytes, Tumor-Infiltrating
Animals

References236

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118835032Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis.Cancer Cell2008https://conductscience.org/library/papers/18835032PubMed
232395366NK Cell-Based Immunotherapies in Cancer.Immune Netw2020https://conductscience.org/library/papers/32395366PubMed
331350295The Tumor Microenvironment Innately Modulates Cancer Progression.Cancer Res2019https://conductscience.org/library/papers/31350295PubMed
41382544Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophils.Br J Haematol1992https://conductscience.org/library/papers/1382544PubMed
537394578Cancer-associated fibroblasts: from basic science to anticancer therapy.Exp Mol Med2023https://conductscience.org/library/papers/37394578PubMed
620226531A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells.Mol Immunol2010https://conductscience.org/library/papers/20226531PubMed
731500313Vascular Endothelial Cell Biology: An Update.Int J Mol Sci2019https://conductscience.org/library/papers/31500313PubMed
836706760Neutrophil-activating therapy for the treatment of cancer.Cancer Cell2023https://conductscience.org/library/papers/36706760PubMed
910365666Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy.Hum Gene Ther1999https://conductscience.org/library/papers/10365666PubMed
1011106265Genetically modified CD34+ cells exert a cytotoxic bystander effect on human endothelial and cancer cells.Clin Cancer Res2000https://conductscience.org/library/papers/11106265PubMed
1119432918Prognostic implications of circulating anti-p53 antibodies in lung cancer--a review.Eur J Cancer Care (Engl)2009https://conductscience.org/library/papers/19432918PubMed
1217974953Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.Cancer Res2007https://conductscience.org/library/papers/17974953PubMed
1324475900Tumor infiltrating B-cells are increased in prostate cancer tissue.J Transl Med2014https://conductscience.org/library/papers/24475900PubMed
1410947988Genes expressed in human tumor endothelium.Science2000https://conductscience.org/library/papers/10947988PubMed
1515894262De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.Cancer Cell2005https://conductscience.org/library/papers/15894262PubMed
1639604727Cancer cells impair monocyte-mediated T cell stimulation to evade immunity.Nature2025https://conductscience.org/library/papers/39604727PubMed
171534242The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation.Annu Rev Immunol1992https://conductscience.org/library/papers/1534242PubMed
1828504320Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.Adv Mater2017https://conductscience.org/library/papers/28504320PubMed
1915800326Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.J Clin Oncol2005https://conductscience.org/library/papers/15800326PubMed
2023499742B cells and their mediators as targets for therapy in solid tumors.Exp Cell Res2013https://conductscience.org/library/papers/23499742PubMed

See all 236 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42753002Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.J Immunol Res2026https://conductscience.org/library/papers/42753002PubMed
42690554Pan-cancer analysis identifies ODF2 as a dual prognostic and predictive biomarker for immunotherapy.Discov Oncol2026https://conductscience.org/library/papers/42690554PubMed
42630543Pediatric leukemia: origins, pathogenesis, the role of microenvironment and immunological modulation.Front Immunol2026https://conductscience.org/library/papers/42630543PubMed
41376222Wenshen Zhuanggu Fang reduces breast cancer bone metastasis by regulating macrophage polarization: a bioinformatics analysis combined with experimental validation.J Tradit Chin Med2025https://conductscience.org/library/papers/41376222PubMed
41230088PLGA-based nanoparticles in colorectal cancer immunotherapy: current concepts and future perspectives.Front Pharmacol2025https://conductscience.org/library/papers/41230088PubMed
41097709Macrophages-Target and Tool in Tumor Treatment: Insights from Ovarian Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41097709PubMed
40467942Advancing the potential of nanoparticles for cancer detection and precision therapeutics.Med Oncol2025https://conductscience.org/library/papers/40467942PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39769334

GET https://conductscience.org/api/papers/v1/39769334/references?page=2